Inhibitory effect of miconazole on melanogenesis

被引:28
作者
Mun, YJ [1 ]
Lee, SW
Jeong, HW
Lee, KG
Kim, JH
Woo, WH
机构
[1] Wonkwang Univ, Dept Herbal Resources, Iksan 570749, South Korea
[2] Dongshin Univ, Coll Oriental Med, Dept Pathol, Naju 520714, South Korea
[3] Woosuk Univ, Coll Oriental Med, Dept Pathol, Jeonbuk 565701, South Korea
关键词
miconazole; melanin; tyrosinase; pigmentation;
D O I
10.1248/bpb.27.806
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Miconazole (MIC), a regional antifungal agent, has been used worldwide in the treatment of superficial mycosis. However, the effect of MIC on skin pigmentation is not known. In this study, we investigated the inhibitory effect of MIC on melanogenesis in B16 melanoma cells. Tyrosinase activity and melanin content were dose dependently decreased by MIC as compared with untreated cells. The level of tyrosinase protein expression was reduced with treatment MIC. A decrease in cell proliferation was observed in B 16 cells treated with MIC 30 mum, indicating that the MIC-induced depigmenting effect was caused by inhibition of melanin synthesis and not by destruction of B16 cells. Furthermore, MIC markedly suppressed a-melanocyte stimulating hormone or forskolin-induced tyrosinase activity in B16 cells. Therefore the depigmenting effect of MIC might be due to the inhibition of tyrosinase activity and tyrosinase expression, which eventually slows melanin biosynthesis. These results indicate that MIC may be a useful inhibitor of melanogenesis in B16 cells and suggest that it may have beneficial effects in the treatment of hyperpigmentation disorders such as ephelis and melasma.
引用
收藏
页码:806 / 809
页数:4
相关论文
共 44 条
[1]
CORRELATION BETWEEN THE NUMBER OF MELANOSOMES, TYROSINASE MESSENGER-RNA LEVELS, AND TYROSINASE ACTIVITY IN CULTURED MURINE MELANOMA-CELLS IN RESPONSE TO VARIOUS MELANOGENESIS REGULATORY AGENTS [J].
ANDO, H ;
ITOH, A ;
MISHIMA, Y ;
ICHIHASHI, M .
JOURNAL OF CELLULAR PHYSIOLOGY, 1995, 163 (03) :608-614
[2]
EFFECT OF AZOLES ON THE GLUCURONIDATION OF ZIDOVUDINE BY HUMAN LIVER UDP-GLUCURONOSYLTRANSFERASE [J].
ASGARI, M ;
BACK, DJ .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (06) :1634-1635
[3]
INHIBITION OF HUMAN ADRENAL STEROIDOGENIC ENZYMES INVITRO BY IMIDAZOLE DRUGS INCLUDING KETOCONAZOLE [J].
AYUB, M ;
LEVELL, MJ .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1989, 32 (04) :515-524
[4]
KETOCONAZOLE IN ATOPIC-DERMATITIS - THERAPEUTIC RESPONSE IS CORRELATED WITH DECREASE IN SERUM IGE [J].
BACK, O ;
SCHEYNIUS, A ;
JOHANSSON, SGO .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1995, 287 (05) :448-451
[5]
P-450 epoxygenase and NO synthase inhibitors reduce cerebral blood flow response to N-methyl-D-aspartate [J].
Bhardwaj, A ;
Northington, FJ ;
Carhuapoma, JR ;
Falck, JR ;
Harder, DR ;
Traystman, RJ ;
Koehler, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (04) :H1616-H1624
[6]
TREATMENT OF ORAL CANDIDIASIS IN DEBILITATED PATIENTS WITH MICONAZOLE - NEW POTENT ANTIFUNGAL DRUG [J].
BRINCKER, H .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1976, 8 (02) :117-120
[7]
BRINCKER H, 1978, ACTA MED SCAND, V204, P123
[8]
Cyclic AMP a key messenger in the regulation of skin pigmentation [J].
Buscà, R ;
Ballotti, R .
PIGMENT CELL RESEARCH, 2000, 13 (02) :60-69
[9]
Conn H, 2000, LASER SURG MED, V26, P201, DOI 10.1002/(SICI)1096-9101(2000)26:2<201::AID-LSM11>3.0.CO
[10]
2-0